Christos Mantzoros is an Internal Medicine provider in Boston, Massachusetts. Dr. Mantzoros is rated as a Distinguished provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Obesity, Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes (T2D), Hormone Replacement Therapy (HRT), and Gastric Bypass.

Caroline Apovian is a Bariatric Medicine provider in Boston, Massachusetts. Dr. Apovian is rated as a Distinguished provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Abdominal Obesity Metabolic Syndrome, Gastric Bypass, and Gastrostomy.

Joann Manson is a primary care provider, practicing in Endocrinologist in Boston, Massachusetts. Dr. Manson is rated as an Advanced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Menopause, Type 2 Diabetes (T2D), Coronary Heart Disease, Hormone Replacement Therapy (HRT), and Tubal Ligation.

Lester Shoap is an Internal Medicine provider in Chestnut Hill, Massachusetts. Dr. Shoap is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, High Cholesterol, and Atrial Fibrillation.

Dr. Kathryn Rexrode serves as Chief of the Division of Women’s Health in the Department of Medicine and is a Professor of Medicine at Harvard Medical School. She is a board-certified general internist with a predominantly women’s health practice as a primary care physician at the BWH Gretchen S. and Edward A. Fish Center for Women’s Health (Fish Center). Dr. Rexrode received her MD from Case Western Reserve School of Medicine and completed her residency in primary care at BWH. She then completed an epidemiology research fellowship at BWH and earned her MPH from the Harvard T.H. Chan School of Public Health.In her role as Division Chief, Dr. Rexrode leads efforts to advance the health of women through research, clinical care, medical education and advocacy. She leads several NIH-funded research projects related to stroke and cardiovascular disease in women.  She has a particular interest in metabolic factors, hormonal exposures and sex-specific risk factors for cardiovascular disease.  Dr. Rexrode is also the Faculty Director for the Office for Women’s Careers in the Center for Diversity and Inclusion where she works to support women’s careers and their academic advancement, to address issues of diversity and inclusion, and to reduce the impact of unconscious bias. In this role, she also leads the Women’s Leadership Program for women junior faculty at BWH and has lectured widely on leadership skills for women in academic medicine. In her clinical practice at the Fish Center, Dr. Rexrode has a focus in women’s health. Dr. Rexrode is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Stroke, Coronary Heart Disease, Osteoporosis, Hormone Replacement Therapy (HRT), and Tubal Ligation.

Tobin Abraham is an Internal Medicine specialist and an Endocrinologist in Chestnut Hill, Massachusetts. Dr. Abraham is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Type 2 Diabetes (T2D), and Thyroid Nodule.

Christian T. Ruff, MD, MPH is the Director of General Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Associate Professor of Medicine at Harvard Medical School. Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his masters of public health from the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.Dr. Ruff is a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials. Dr. Ruff has served on international clinical guideline committees and has been invited to give hundreds of lectures nationally and internationally. He has authored many scholarly articles, editorials, reviews, and book chapters that include the New England Journal of Medicine, Lancet, Journal of the American Medical Association, American Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Nature Reviews Cardiology. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Heart Attack, Heart Failure, Cardiac Ablation, and Angioplasty.

Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy.

Barbara Kahn is an Internal Medicine specialist and an Endocrinologist in Boston, Massachusetts. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Type B Insulin Resistance Syndrome, Obesity, Type 2 Diabetes (T2D), Mccune-Albright Syndrome, and Hip Resurfacing.

Murray Mittleman is an Internal Medicine provider in Boston, Massachusetts. Dr. Mittleman is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Heart Attack, Atherosclerosis, High Cholesterol, Heart Transplant, and Aneurysm Repair.

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Lau is the director of the Brigham and Women's Hospital Women's Heart Health program and Assistant Professor of Medicine at Harvard Medical School. She received her medical degree from the Warren Alpert Medical School of Brown University and Masters in Public Health from the Harvard T.H. Chan School of Public Health. She trained in internal medicine at Brigham and Women's Hospital, where she also served as Chief Medical Resident. She subsequently completed cardiovascular disease fellowship and advanced echocardiography training at Massachusetts General Hospital. She is board certified in cardiology, echocardiography, and internal medicine. Dr. Lau specializes in women's cardiovascular health, general cardiology, and echocardiography. Her research focuses on understanding how biologic sex differences and female-specific risk factors contribute to heart disease.Dr. Lau specializes in women's cardiovascular health, general cardiology, and echocardiography. Her research focuses on how biologic differences between men and women and female-specific risk factors contribute to heart disease. Dr. Lau is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Long QT Syndrome 1, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Vertebroplasty, and Knee Replacement.

Dr. Benjamin M. Scirica is a cardiovascular medicine specialist and Professor of Medicine at Harvard Medical School (HMS). He is a Senior Investigator at the Thrombolysis and Myocardial Infarction (TIMI) Study Group and leads the Accelerator for Clinical Transformation, a group that has developed a series of remote disease management programs.Dr. Scirica received his medical degree from Harvard Medical School. He completed an internal medicine residency and a cardiovascular disease fellowship at BWH. He also completed a research fellowship in cardiovascular disease with the TIMI Study Group at BWH and received a master’s degree in public health from Harvard School of Public Health. Dr. Scirica is board certified in cardiovascular disease. His is an attending physician in the Levine Cardiac Intensive Care Unit and in the Watkins Cardiovascular Clinic at BWH. His research interests center on identifying and applying novel therapeutic and care delivery strategies across the spectrum of cardiometabolic disease. Dr. Scirica is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Cardiac Arrest, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

John Keaney is a Cardiologist in Boston, Massachusetts. Dr. Keaney is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, Heart Attack, Atrial Fibrillation, Pacemaker Implantation, and Cardiac Ablation.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Dr. Michelle O'Donoghue is the McGillycuddy-Logue Distinguished Chair in Cardiology at Brigham and Women’s Hospital (BWH). She is also an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. O’Donoghue received her medical degree from Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine and a cardiology fellowship at Massachusetts General Hospital and a Master’s Degree in Public Health from Harvard. Dr. O’Donoghue is board certified in cardiovascular disease.The author of numerous peer-reviewed publications, Dr. O’Donoghue’s research focuses on optimizing the management of acute coronary syndromes (heart attacks), the study of women and heart disease, the use of existing biomarkers for risk stratification, potential new therapeutic targets, as well as the discovery and evaluation of novel biomarkers using “omic”-based technology. Dr. O'donoghue is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Acute Coronary Syndrome, Unstable Angina, Heart Attack, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Ellen Seely is an Endocrinologist in Boston, Massachusetts. Dr. Seely is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. Her top areas of expertise are Gestational Diabetes, Type 2 Diabetes (T2D), Congenital Adrenal Hyperplasia (CAH), Congenital Lipoid Adrenal Hyperplasia, and Hormone Replacement Therapy (HRT).